BiomX (PHGE) Capital Expenditures (2019 - 2024)
BiomX (PHGE) posted Capital Expenditures of $11000.0 for Q4 2024, up 10.0% sequentially from $10000.0 in Q3 2024, and up 57.14% YoY from $7000.0 in Q1 2024.
BiomX (PHGE) Capital Expenditures (2019 - 2024) Analysis & Trends
BiomX has reported Capital Expenditures for 6 years, with the latest figure at $11000.0 in Q4 2024.
- Quarterly Capital Expenditures rose 57.14% year-over-year to $11000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2025 was $28000.0 (down 53.33% YoY) and the FY2025 annual result came in at $2000.0, down 93.33% from the prior year.
- Capital Expenditures advanced to $11000.0 in Q4 2024 per PHGE's latest filing, from $10000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $1.5 million in Q1 2021 and troughed at $1000.0 in Q2 2023.
- A 5-year average of $270777.8 and a median of $43000.0 in 2022 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2021 and 2022: Capital Expenditures soared 579.27% in 2021, then plunged 99.54% in 2022.
- Over 5 years, Capital Expenditures stood at $347000.0 in 2020, then slumped by 70.32% to $103000.0 in 2021, then plunged by 68.93% to $32000.0 in 2022, then slumped by 78.12% to $7000.0 in 2023, then jumped by 57.14% to $11000.0 in 2024.
- According to Business Quant data, Capital Expenditures over the past three periods registered $11000.0, $10000.0, and $7000.0 for Q4 2024, Q3 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 34.68 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.26 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 251.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -73.57 Mn |
| 10 | BiomX | 361,408.40 | -806,591.60 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 11,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | 32,000.00 |
| Sep 30, 2023 | 32,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 10,000.00 |
| Mar 31, 2023 | 10,000.00 |
| Dec 31, 2022 | 32,000.00 |
| Dec 31, 2022 | 32,000.00 |
| Sep 30, 2022 | 6,000.00 |
| Sep 30, 2022 | 6,000.00 |
| Jun 30, 2022 | 54,000.00 |
| Jun 30, 2022 | 54,000.00 |
| Mar 31, 2022 | 20,000.00 |
| Mar 31, 2022 | 20,000.00 |